Riding the Digital Health Wave: The L.E.K. Digital Excellence Framework Klaus Boehncke Guillaume Duparc Monish Rajpal Stephen Sunderland Read More
Life Sciences & Pharma Special Report Making the AI Leap: Boosting Singapore’s Competitiveness in Biotech December 17, 2020 Following years of investment through artificial intelligence (AI)-centric venture funds and government grants, Singapore has moved beyond applying AI to…
Life Sciences & Pharma Executive Insights Approaching Japan’s Increasingly Challenging and Subjective Drug Pricing Environment November 17, 2020 Companies need to understand Japan’s pricing system and anticipate and plan for potential challenges both in advance of and subsequent to launch.
Life Sciences & Pharma Published Articles 2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers September 24, 2020 In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations.
Life Sciences & Pharma Special Report Gene Therapy: Competitive Dynamics and Commercial Implications September 11, 2020 After more than 25 years of investment, commercialization of gene therapies (GTs) has reached a pivotal point.
MedTech Published Articles COVID-19: An Accelerator of Existing Trends August 5, 2020 There is no doubt that COVID-19 has had a severe impact on the US healthcare ecosystem (as well as the rest of the economy) as providers have focused on…
Life Sciences & Pharma Executive Insights How Value-Based Contracts Bring Value to Biopharma July 23, 2020 Biopharmaceutical executives have engaged in extensive debates about the need for and effectiveness of value-based contracts (VBCs) ever since the…
Healthcare Services Executive Insights Healthcare Provider Strategy for the Post-COVID-19 World July 15, 2020 Providers are on high alert due to the global impact of COVID-19. Current and potential future waves of infections, lockdowns and reopenings — and their…
Healthcare Services Executive Insights Meeting People Where They Are: Effective Strategies for Social Determinants of Health July 9, 2020 Skyrocketing medical costs, clinical variation and outcomes that underindex those of other developed nations have risen to the forefront as key issues…
Life Sciences & Pharma Executive Insights New Drug Discovery Paradigm: Advances in 3D Tissue Models and Applications July 9, 2020 We discuss recent advances in the field of 3D tissue models and their potential to improve the drug discovery paradigm.
Life Sciences & Pharma Presentations COVID-19 Implications for Biopharma June 25, 2020 This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term.
Life Sciences & Pharma Presentations COVID-19 Therapeutic Research and Development Landscape June 3, 2020 The following materials provide a snapshot of the unprecedented scope and speed of biopharma’s therapeutics research and development (R&D) response to…
Life Sciences & Pharma Executive Insights AI in Life Sciences: Emerging Business Models April 24, 2020 The presence of artificial intelligence (AI) in life sciences is growing quickly as a result of multiple AI companies focusing on drug discovery and…
